Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May 20;16(2):519-533.
doi: 10.1007/s13167-025-00412-9. eCollection 2025 Jun.

Vision transformer-based stratification of pre/diabetic and pre/hypertensive patients from retinal photographs for 3PM applications

Affiliations

Vision transformer-based stratification of pre/diabetic and pre/hypertensive patients from retinal photographs for 3PM applications

Krithi Pushpanathan et al. EPMA J. .

Abstract

Objective: Diabetes and hypertension pose significant health risks, especially when poorly managed. Retinal evaluation though fundus photography can provide non-invasive assessment of these diseases, yet prior studies focused on disease presence, overlooking control statuses. This study evaluated vision transformer (ViT)-based models for assessing the presence and control statuses of diabetes and hypertension from retinal images.

Methods: ViT-based models with ResNet-50 for patch projection were trained on images from the UK Biobank (n = 113,713) and Singapore Epidemiology of Eye Diseases study (n = 17,783), and externally validated on the Singapore Prospective Study Programme (n = 7,793) and the Beijing Eye Study (n = 6064). Model performance was evaluated using the area under the receiver operating characteristic curve (AUROC) for multiple tasks: detecting disease, identifying poorly controlled and well-controlled cases, distinguishing between poorly and well-controlled cases, and detecting pre-diabetes or pre-hypertension.

Results: The models demonstrated strong performance in detecting disease presence, with AUROC values of 0.820 for diabetes and 0.781 for hypertension in internal testing. External validation showed AUROCs ranging from 0.635 to 0.755 for diabetes, and 0.727 to 0.832 for hypertension. For identifying poorly controlled cases, the performance remained high with AUROCs of 0.871 (internal) and 0.655-0.851 (external) for diabetes, and 0.853 (internal) and 0.792-0.915 (external) for hypertension. Detection of well-controlled cases also yielded promising results for diabetes (0.802 [internal]; 0.675-0.838 [external]), and hypertension (0.740 [internal] and 0.675-0.807 [external]). In distinguishing between poorly and well-controlled disease, AUROCs were more modest with 0.630 (internal) and 0.512-0.547 (external) for diabetes, and 0.651 (internal) and 0.639-0.683 (external) for hypertension. For pre-disease detection, the models achieved AUROCs of 0.746 (internal) and 0.523-0.590 (external) for pre-diabetes, and 0.669 (internal) and 0.645-0.679 (external) for pre-hypertension.

Conclusion: ViT-based models show promise in classifying the presence and control statuses of diabetes and hypertension from retinal images. These findings support the potential of retinal imaging as a tool in primary care for opportunistic detection of diabetes and hypertension, risk stratification, and individualised treatment planning. Further validation in diverse clinical settings is warranted to confirm practical utility.

Supplementary information: The online version contains supplementary material available at 10.1007/s13167-025-00412-9.

Keywords: Deep learning; Diabetes; Health risk assessment; Hypertension; Improved individual outcomes; Innovative screening programs; Opportunistic screening; Predictive Preventive Personalized Medicine (PPPM / 3PM); Preventable diseases; Protection against health-to-disease transition; Retinal image; Risk stratification.

PubMed Disclaimer

Conflict of interest statement

Competing interestsThe authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Schematic of the development and evaluation of vision transformer-based models. ViT*, vision transformer; MHA, multi head attention; MLP, multi-layer perceptron
Fig. 2
Fig. 2
Receiver operating curves demonstrating the classification performance of vision transformer-based models from retinal fundus images across various diabetes outcomes. a Presence of diabetes, b poorly controlled diabetes (compared to non-diseased individuals), c well-controlled diabetes (compared to non-diseased individuals), d differentiating poorly controlled and well-controlled diabetes, e pre-diabetes (compared to healthy individuals)
Fig. 3
Fig. 3
Receiver operating curves demonstrating the classification performance of vision transformer-based models from retinal fundus images across various hypertension outcomes. a Presence of hypertension, b poorly controlled hypertension (compared to non-diseased individuals), c well-controlled hypertension (compared to non-diseased individuals), d differentiating poorly controlled and well-controlled hypertension, e pre-hypertension (compared to healthy individuals)
Fig. 4
Fig. 4
Receiver Operating Curves Demonstrating the Classification Performance of Vision Transformer-Based Models from Retinal Fundus Images Across Various Hypertension Outcomes among People with Diabetes. a Presence of hypertension, b poorly controlled hypertension (compared to non-diseased individuals), c well-controlled hypertension (compared to non-diseased individuals), d differentiating poorly controlled and well-controlled hypertension, e Pre-hypertension (compared to healthy individuals)

Similar articles

References

    1. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398(10304):957–80. 10.1016/s0140-6736(21)01330-1. - PMC - PubMed
    1. Ong KL, Stafford LK, Mclaughlin SA, Boyko EJ, Vollset SE, Smith AE, et al. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2023;402(10397):203–34. 10.1016/s0140-6736(23)01301-6. - PMC - PubMed
    1. Ogurtsova K, Guariguata L, Noël CB, Ruiz PL-D, Sacre JW, Karuranga S, et al. IDF diabetes Atlas: global estimates of undiagnosed diabetes in adults for 2021. Diab Res Clin Pract. 2022;2022(183):109118. 10.1016/j.diabres.2021.109118. - PubMed
    1. Kario K, Okura A, Hoshide S, Mogi M. The WHO Global report 2023 on hypertension warning the emerging hypertension burden in globe and its treatment strategy. Hypertens Res. vol 5. England: © 2024. The Author(s), under exclusive licence to The Japanese Society of Hypertension.; 2024. p. 1099–102. - PubMed
    1. Man REK, Gan AHW, Fenwick EK, Gan ATL, Gupta P, Sabanayagam C, et al. Prevalence, determinants and association of unawareness of diabetes, hypertension and hypercholesterolemia with poor disease control in a multi-ethnic Asian population without cardiovascular disease. Popul Health Metr. 2019;17(1):17. 10.1186/s12963-019-0197-5. - PMC - PubMed

LinkOut - more resources